Gan And Lee Pharmaceuticals, Usa
Clinical trials sponsored by Gan And Lee Pharmaceuticals, Usa, explained in plain language.
-
Could a biweekly shot rival weekly Weight-Loss drugs?
Disease control CompletedThis study tests an experimental drug called GZR18, given as an injection every two weeks, to help people with obesity or overweight lose weight. It compares three doses of GZR18 against a placebo and an existing weekly weight-loss drug, tirzepatide. Participants do not have type…
Phase: PHASE2 • Sponsor: Gan and Lee Pharmaceuticals, USA • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New Weight-Loss shot shows promise in chinese trial
Disease control CompletedThis study tested an experimental injection called GZR18 in 340 Chinese adults who are obese or overweight. The goal was to see if it helps with weight loss over 30 weeks compared to a placebo. Participants also followed a stable diet and exercise plan. The results will show how …
Phase: PHASE2 • Sponsor: Gan and Lee Pharmaceuticals, USA • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC